Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Byrne

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|October 7, 2006
Emergency naloxone for heroin overdose: over the counter availability needs careful considerationAndrew Byrne
Annals of Internal Medicine|August 5, 2009
Concerns about consensus guidelines for QTc interval screening in methadone treatmentAndrew Byrne
BMJ (Clinical Research Ed.)|September 8, 2007
Drug misusers and incentives: Methadone works if used properlyAndrew Byrne
BMJ (Clinical Research Ed.)|May 7, 2013
Maintenance treatment is not rocket scienceAndrew Byrne
The American Journal of Psychiatry|November 3, 2007
Data do not support buprenorphine as a first-line treatment for addictionAndrew Byrne, Alex Wodak
BMJ (Clinical Research Ed.)|January 10, 2006
Is methadone too dangerous for opiate addiction? Methadone is still needed in addiction treatmentsAndrew Byrne, Richard Hallinan
Lancet (London, England)|February 6, 2007
Methadone and QTc prolongationAndrew Byrne, Barry Stimmel
Australian and New Zealand Journal of Public Health|June 11, 2002
HIV seroconversionAndrew Byrne, Richard Hallinan
Drug and Alcohol Review|January 23, 2003
Administration of a lighter-coloured methadone liquidAndrew Byrne, Richard Hallinan, Anne Love
Drug and Alcohol Review|June 15, 2007
Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reductionRichard Hallinan, Andrew Byrne, Gregory J Dore
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|October 7, 2006
Emergency naloxone for heroin overdose: over the counter availability needs careful considerationAndrew Byrne
Annals of Internal Medicine|August 5, 2009
Concerns about consensus guidelines for QTc interval screening in methadone treatmentAndrew Byrne
BMJ (Clinical Research Ed.)|September 8, 2007
Drug misusers and incentives: Methadone works if used properlyAndrew Byrne
BMJ (Clinical Research Ed.)|May 7, 2013
Maintenance treatment is not rocket scienceAndrew Byrne
The American Journal of Psychiatry|November 3, 2007
Data do not support buprenorphine as a first-line treatment for addictionAndrew Byrne, Alex Wodak
BMJ (Clinical Research Ed.)|January 10, 2006
Is methadone too dangerous for opiate addiction? Methadone is still needed in addiction treatmentsAndrew Byrne, Richard Hallinan
Lancet (London, England)|February 6, 2007
Methadone and QTc prolongationAndrew Byrne, Barry Stimmel
Australian and New Zealand Journal of Public Health|June 11, 2002
HIV seroconversionAndrew Byrne, Richard Hallinan
Drug and Alcohol Review|January 23, 2003
Administration of a lighter-coloured methadone liquidAndrew Byrne, Richard Hallinan, Anne Love
Drug and Alcohol Review|June 15, 2007
Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reductionRichard Hallinan, Andrew Byrne, Gregory J Dore
Pageof 4